Hvsen
300871.SZHvsen Biotechnology Co., Ltd. Price (300871.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
165,982,423
(0.333)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Hvsen Biotechnology Co., Ltd.Currency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
257,783,400.00
+0% |
399,715,931.00
+55% |
421,874,231.00
+6% |
427,217,126.00
+1% |
777,458,548.00
+82% |
996,216,817.00
+28% |
1,022,900,792.00
+3% |
1,019,758,798.00
0% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 122,002,000.00 | 197,015,544.00 | 238,147,430.00 | 263,549,480.00 | 489,588,548.00 | 725,496,209.00 | 797,537,428.00 | 809,956,079.00 | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
135,781,400.00
+0% |
202,700,387.00
+49% |
183,726,801.00
-9% |
163,667,646.00
-11% |
287,870,000.00
+76% |
270,720,608.00
-6% |
225,363,364.00
-17% |
209,802,719.00
-7% |
|||||||||||
| Gross Profit Ratio | (0.53%) | (0.51%) | (0.44%) | (0.38%) | (0.37%) | (0.27%) | (0.22%) | (0.21%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 12,793,200.00 | 17,952,318.00 | 20,356,210.00 | 21,108,719.00 | 28,381,969.00 | 46,887,602.00 | 40,138,389.00 | 27,658,858.00 | |||||||||||
| General and Administrative | 15,386,000.00 | -19,966,860.60 | -24,465,146.18 | -25,167,339.38 | 13,706,452.00 | 17,327,551.00 | 11,091,990.00 | 10,544,106.00 | |||||||||||
| Selling, General & Admin... | 64,628,300.00 | 37,892,931.00 | 22,276,690.00 | 13,653,413.00 | 66,262,170.00 | 64,481,710.00 | 59,519,508.00 | 155,401,855.00 | |||||||||||
| Selling & Marketing Exp... | 49,242,300.00 | 57,859,792.00 | 46,741,836.00 | 38,820,752.00 | 52,555,717.00 | 47,154,158.00 | 48,427,518.00 | 55,628,365.00 | |||||||||||
| Depreciation and Amortiz... | 7,279,300.00 | 10,196,600.00 | 12,871,800.00 | 12,650,445.00 | 19,082,343.00 | 28,540,374.00 | 62,694,863.00 | 120,389,300.00 | |||||||||||
| Other Expenses | 3,671,000.00 | 147,715.00 | 2,433,831.00 | 3,065,206.00 | -484,899.71 | -195,492.57 | -2,447,448.93 | 11,659,021.00 | |||||||||||
| Total Operating Expenses | 80,058,800.00 | 97,218,933.00 | 88,245,356.00 | 80,361,777.00 | 109,849,030.00 | 134,530,503.00 | 146,037,660.00 | 194,719,734.00 | |||||||||||
| Cost and Exponses | 202,060,800.00 | 294,234,478.00 | 326,392,786.00 | 343,911,257.00 | 599,437,578.00 | 860,026,713.00 | 943,575,088.00 | 1,004,675,813.00 | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
54,516,900.00
+0% |
103,379,831.00
+90% |
81,490,052.00
-21% |
78,555,436.00
-4% |
176,517,292.00
+125% |
151,027,846.00
-14% |
59,156,949.00
-61% |
15,082,985.00
-75% |
|||||||||||
| Operating Income Ratio | (0.21%) | (0.26%) | (0.19%) | (0.18%) | (0.23%) | (0.15%) | (0.06%) | (0.01%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 1,550,630.00 | 1,123,775.00 | 2,025,863.00 | 6,532,684.00 | 7,682,795.00 | 4,757,845.00 | 3,953,121.00 | |||||||||||
| Interest Expenses | 155,300.00 | 804,858.00 | 3,822,030.00 | 5,235,384.00 | 2,301,368.00 | 2,872,419.00 | 18,375,863.00 | 28,215,682.00 | |||||||||||
| Total Other Income/Exp... | 3,245,800.00 | 344,049.00 | 177,630.00 | 46,449.00 | -484,900.00 | -195,492.00 | -2,447,449.00 | -2,641,440.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 65,919,300.00 | 114,370,000.00 | 96,094,900.00 | 93,441,834.00 | 197,735,328.00 | 182,645,582.00 | 138,226,633.00 | 161,378,255.00 | |||||||||||
| EBITDA ratio | (0.25%) | (0.29%) | (0.27%) | (0.24%) | (0.26%) | (0.18%) | (0.15%) | (0.16%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 58,188,100.00 | 103,723,876.00 | 81,667,678.00 | 78,601,885.00 | 176,032,392.00 | 150,832,354.00 | 56,709,500.00 | 12,441,545.00 | |||||||||||
| Income Before Tax Ratio | (0.23%) | (0.26%) | (0.19%) | (0.18%) | (0.23%) | (0.15%) | (0.06%) | (0.01%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 8,789,800.00 | 15,314,390.00 | 10,266,105.00 | 9,835,531.00 | 25,876,284.00 | 17,966,819.00 | 4,003,024.00 | -4,339,273.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 49,423,100.00
+0% |
88,424,284.00
+79% |
71,401,573.00
-19% |
68,766,353.00
-4% |
150,156,108.00
+118% |
132,865,534.00
-12% |
52,706,475.00
-60% |
16,780,818.00
-68% |
|||||||||||
| Net Income Ratio | (0.19%) | (0.22%) | (0.17%) | (0.16%) | (0.19%) | (0.13%) | (0.05%) | (0.02%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.41 | 0.74 | 0.59 | 0.41 | 0.91 | 0.80 | 0.32 | 0.10 | |||||||||||
| Diluted EPS | 0.41 | 0.74 | 0.59 | 0.41 | 0.91 | 0.80 | 0.32 | 0.10 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 165,760,516.00 | 119,492,277.00 | 120,339,730.00 | 165,760,516.00 | 165,760,543.00 | 166,081,917.00 | 165,431,498.00 | 165,982,423.00 | |||||||||||
| Diluted Share Outstanding | 165,760,516.00 | 119,492,277.00 | 120,339,730.00 | 165,760,516.00 | 165,760,543.00 | 166,081,917.00 | 165,431,498.00 | 165,982,423.00 | |||||||||||